Celularity Inc-a (CELU) 13F Investor Activity Report (Q2 2026)

CELU ranks #6742 out of 37701 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

CELU is a disclosed holding of Ken Griffin (Citadel Advisors LLC), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

40 institutions disclose a position in CELU, but none treat it as a major bet — even C V Starr & Co Inc, its most concentrated holder, allocates just 0.8% of its own portfolio to it.

CELU reported a net loss of $71.1M over the trailing twelve months.

• Not yet profitable — net loss of $71.1M over the trailing twelve months
• Revenue declined 62.8% year over year
• Net income declined year over year, from -$55.6M to -$71.1M
• Operating cash flow was negative, using $13.3M in cash
• Current ratio of 0.15x — below the conventional 1.5x liquidity buffer
• Liabilities run 48463.67x equity — a highly leveraged balance sheet worth noting